August 26, 2011
BOTOX(R) (onabotulinumtoxinA) Receives U.S. FDA Approval for the Treatment of Urinary Incontinence in Adults with Neurological Conditions Including Multiple Sclerosis
- /
- /
IRVINE, Calif., Aug 24, 2011 (BUSINESS WIRE) — Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has…
